Genetic polymorphism of CYP2D6 and CYP2C19 in East- and Southern African populations including psychiatric patients

By Dandara Collet   Mutowembwa Masimirembwa Collen   Magimba Ayoub   Sayi Jane   Kaaya Sylvia   Sommers De K.   Snyman J.R.   Hasler Julia Anne  

European Journal of Clinical Pharmacology, Vol. 57, Iss. 1, 2001-04 ,pp. : 11-17

Springer Publishing Company

Access to resources Recommend Favorite

Polymorphism of CYP2C19 and Gastric Emptying in Patients with Proton Pump Inhibitor-resistant Gastric Ulcers

By Wada F   Murase K   Isomoto H   Soda H   Takeshima F   Omagari K   Mizuta Y   Tsukamoto K   Murata I   Kohno S  

The Journal of International Medical Research, Vol. 30, Iss. 4, 2002-07 ,pp. : 413-421

Field House Publishing

Access to resources Recommend Favorite

The Influence of CYP2C19 Genetic Polymorphism on the Pharmacokinetics/- Pharmacodynamics of Proton Pump Inhibitor-Containing Helicobacter pylori Treatments

By  

Current Drug Metabolism, Vol. 13, Iss. 9, 2012-11 ,pp. : 1303-1312

Bentham Science Publishers

Access to resources Recommend Favorite

Absolute bioavailability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenous and oral administrations

By Uno Tsukasa   Niioka Takenori   Hayakari Makoto   Yasui-Furukori Norio   Sugawara Kazunobu   Tateishi Tomonori  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 2, 2007-02 ,pp. : 143-149

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetic differences between the enantiomers of lansoprazole and its metabolite, 5-hydroxylansoprazole, in relation to CYP2C19 genotypes

By Miura M.   Tada H.   Yasui-Furukori N.   Uno T.   Sugawara K.   Tateishi T.   Suzuki T.  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 9, 2004-11 ,pp. : 623-628

Springer Publishing Company

Access to resources Recommend Favorite